
btw ...... I also .....left my heart in San Francisco .....

Mr. Success
Hey Phil--Brainteaser wrote:Can we get Dr Dake set up in Singapore or somewhere, where he's free to study and treat patients to his heart's content and make big bucks - without all this Western medicine sham study nonsense? It must be driving him insane!
Phil
He also receives money from big biomedical companies that deal in stents. Who was the first to start using stents for "Liberation"? I think he was the first Dr. I heard was using stents, but i could be wrong.cheerleader wrote: Hey Phil--
Dr. Dake has a well-established practice at Stanford, and he's also got an endowed chair (1 million- Thelma and Henry Doelger prize) so he's not really looking to move. His son's at Stanford, too.
I guess it all depends on what the study is geared towards. Yes, obviously a longer term study would have more scientific teeth, but I doubt when that happens, any sham surgeries will be included, just a guess. Shorter term, seems more palatable. I do think though that a short termer right now is going to give CCSVI a serious kick in the pants like it needs, and get many other institutions off the fence and into the fray. By including the shams in the short term study, the placebo effect will be muted, not eliminated but certainly quieted down, keeping an eye towards the future criticism of said study of course. Hopefully someday there will be a more low key long term tracking of treated patients, by this time next year there will be plenty of 1 year plus people to choose from, and some 2 year people too!Cece wrote:I'd missed that bit of info somehow. Back in May, when Dr. Sclafani kept suggesting that a two-year randomized trial would be needed, that was cause for some angst. It makes sense, if they are studying CCSVI, short-term outcomes are acceptable; if they're studying MS, longer-term outcomes might be better.CureIous wrote:I think it's always been known that the waiting line post-study for the fulfillment of the procedure from Dake was fairly short.
Rokkit--He's looking at the symptoms that are clinically associated with venous insufficiency (stuff you see in people suffering from CO2 poisoning, diffuse cerebral hypoxia or low O2 levels)--fatigue, cognitive fog, heat intolerance, urgent bladder, spasms. These are the "MS symptoms" that seem to be affected most in the very beginning when venous return is established. The other symptoms that are due to long term axonal damage may not resolve in three months (if ever)....and Dr. Dake doesn't want to wait years to treat the rest of the patients in the placebo end of the trial.Rokkit wrote:Dr. Dake must think that significant benefit will likely be apparent in the short 3 month timeframe or he wouldn't design the trial this way. That is very encouraging to me.
Thanks, Cheer, I think focusing on those symptoms is brilliant and the only way to get this thing off high center any time soon.cheerleader wrote:Rokkit--He's looking at the symptoms that are clinically associated with venous insufficiency (stuff you see in people suffering from CO2 poisoning, diffuse cerebral hypoxia or low O2 levels)--fatigue, cognitive fog, heat intolerance, urgent bladder, spasms. These are the "MS symptoms" that seem to be affected most in the very beginning when venous return is established. The other symptoms that are due to long term axonal damage may not resolve in three months (if ever)....and Dr. Dake doesn't want to wait years to treat the rest of the patients in the placebo end of the trial.
cheer